Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tyra Bioscience (TYRA)
NASDAQ:TYRA
Holding TYRA?
Track your performance easily
TYRA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$10.38 - $25.14
Previous Close$24.36
Volume249.50K
Average Volume (3M)173.23K
Market Cap
$1.29B
Enterprise Value$918.96M
Total Cash (Recent Filing)$373.80M
Total Debt (Recent Filing)$6.40M
Price to Earnings (P/E)―
Beta2.02
Next Earnings
Oct 31, 2024EPS Estimate
-$0.4Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.69
Shares Outstanding52,806,137
10 Day Avg. Volume193,100
30 Day Avg. Volume173,230
Standard Deviation0.23
R-Squared0.05
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)3.42
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-31.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-14.78
Forecast
1Y Price Target
$29.75Price Target Upside22.13% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Tyra Bioscience News
PremiumCompany Announcements
Tyra Biosciences’ Q3 2024: Clinical Progress and Financial Resilience
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TYRA FAQ
What was Tyra Bioscience’s price range in the past 12 months?
Tyra Bioscience lowest stock price was $10.38 and its highest was $25.14 in the past 12 months.
What is Tyra Bioscience’s market cap?
Currently, no data Available
When is Tyra Bioscience’s upcoming earnings report date?
Tyra Bioscience’s upcoming earnings report date is Oct 31, 2024 which is 26 days ago.
How were Tyra Bioscience’s earnings last quarter?
Tyra Bioscience released its earnings results on Aug 07, 2024. The company reported -$0.32 earnings per share for the quarter, beating the consensus estimate of -$0.408 by $0.088.
Is Tyra Bioscience overvalued?
According to Wall Street analysts Tyra Bioscience’s price is currently Undervalued.
Does Tyra Bioscience pay dividends?
Tyra Bioscience does not currently pay dividends.
What is Tyra Bioscience’s EPS estimate?
Tyra Bioscience’s EPS estimate is -$0.4.
How many shares outstanding does Tyra Bioscience have?
Tyra Bioscience has 52,806,137 shares outstanding.
What happened to Tyra Bioscience’s price movement after its last earnings report?
Tyra Bioscience reported an EPS of -$0.32 in its last earnings report, beating expectations of -$0.408. Following the earnings report the stock price went up 4.308%.
Which hedge fund is a major shareholder of Tyra Bioscience?
Among the largest hedge funds holding Tyra Bioscience’s share is RA Capital Management. It holds Tyra Bioscience’s shares valued at 167M.
---
Tyra Bioscience Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$29.75 (22.13% Upside)
$29.75 (22.13% Upside)
Hedge Fund Trend
Decreased
By 1.2M Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
75.37%
12-Months-Change
Fundamentals
Return on Equity
-26.32%
Trailing 12-Months
Asset Growth
56.98%
Trailing 12-Months
Company Description
Tyra Bioscience
Tyra Biosciences Inc is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer.
---
TYRA Stock 12 Month Forecast
Average Price Target
$29.75
▲(22.13% Upside)
Technical Analysis
Best Analysts Covering TYRA
1 Year
1 Year Success Rate
15/15 ratings generated profit
1 Year Average Return
+61.93%
reiterated a buy rating 4 months ago
Copying Mitchell Kapoor's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +61.93% per trade.
---